Genpact currently trades at $43.18 per share and has shown little upside over the past six months, posting a middling return ...

Charles River Laboratories’s stock price has taken a beating over the past six months, shedding 20.8% of its value and ...

CompanyOverview|NASDAQ:APLD] The artificial intelligence (AI) revolution has ignited a modern gold rush, not for precious ...

Nvidia's stock is making a robust comeback as it approaches its all-time high from March 2025, with significant upward ...

Live Updates Live Coverage Updates appear automatically as they are published. Retail Sales Drop, Market Narrows Losses 10:22 ...